Agreement signedPublished 19 Dec 2024

NLS Pharmaceuticals /
Kadimastem

NLS Pharmaceuticals agrees to buy Kadimastem

Buy side: NLS Pharmaceuticals
Buy sideNLS Pharmaceuticals
Target: Kadimastem
TargetKadimastem
Source · 19 Dec 2024Source-verified
Buy side: NLS Pharmaceuticals
Buy sideNLS Pharmaceuticals
Target: Kadimastem
TargetKadimastem
01 / BuyerNLS Pharmaceuticals
02 / TargetKadimastem
Source-verified
01

What happened

NLS Pharmaceuticals agreed to acquire Kadimastem, according to a filing dated Dec. 19, 2024.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

NLS Pharmaceuticals agrees to buy Kadimastem

This document is the source for the companies, stage and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    The source this page is built from.

    Source-verified
  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.